PATALGARUDI FOR THE TRATMENT OF URINARY TRACT INFECTION

Phase 3

Not yet recruiting

Conditions: Urinary tract infection, site notspecified. Ayurveda Condition: MUTRAKRUCCRAM,

Registration Number: CTRI/2023/08/056351

Lead Sponsor: Dr AARTI SAINI

Brief Summary: Aim

To evaluate the efficacy of Patalgarudi dispersible tablet in the management of lower urinary tract infection

Objectives

To observe the efficacy of Patalgarudi dispersible tablet in the management of lower urinary tract infection

To evaluate the clinical efficacy of Patalgarudi on urine biochemical parameters

To evaluate antibacterial property of Patalgarudi dispersible tablet in vitro study

Detailed Description: Not available

Recruitment & Eligibility

Status: Not Yet Recruiting

Sex: All

Target Recruitment: 40

Inclusion Criteria

Patients presenting with LUTI Any of two or more symptoms described in the context of LUTI Patients irrespective of gender caste and religion Patient between the age group of 20 70 years.

Exclusion Criteria

Below the 20 years or above 70 years Hematuria Renal failure Pyelonephritis Nephrotic syndrome Septicemia Chronic systemic illness uncontrolled DM and HTN HIV Malignancy HBsAg TB.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
WILL SUBSIDE THE SYMPTOMS OF URINARY TRACT INFECTION	21 DAYS

Secondary Outcome Measures

Name	Time	Method
WILL SUBSIDE THE SYMPTOMS OF LOWER URINARY TRACT INFECTION	Dysuria

Trial Locations

Locations (1): Parul Ayurved Hospital
🇮🇳
Vadodara, GUJARAT, India
Parul Ayurved Hospital
🇮🇳Vadodara, GUJARAT, India
DR AARTI SAINI
Principal investigator
7015740055
sainiaarti242@gmail.com